The effects of eight weeks aerobic, resistance, and combined exercises on plasma Irisin levels, insulin resistance and lipid profiles among obese women with metabolic syndrome

Phase 3

• Conditions: Condition 1: Metabolic syndrome. Condition 2: Diabets.; Metabolic syndrome; Diabetes mellitus due to underlying condition; E88.81

• Registration Number: IRCT20180806040721N2
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Having at least 3 components of metabolic syndrome
Women 45-60 years old
No history of any specific disease (cancer, diabetes, cardiovascular problems, Skeletal-muscular problems)

Exclusion Criteria

diagnosed with history of any specific disease (cancer, diabetes, cardiovascular problems, Skeletal-muscular problems)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Irisin. Timepoint: measurement at the beginning of the study (before the intervention) and 2 months after the intervention. Method of measurement: Measurement Plasma Irisin Level Using Elis Kit Made in Germany.

Secondary Outcome Measures

Name	Time	Method
Glocose. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention began. Method of measurement: fasting blood glucose (glucose oxidase) measured.;Insulin. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention began. Method of measurement: The level of insulin was measured by ELISA.;Triglyceride. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention began. Method of measurement: triglyceride (PAP-GPO / lipase) measured.